In-Depth Implantable Remote Patient Monitoring Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Implantable Remote Patient Monitoring Devices Market From 2025 to 2029?
The market size of implantable remote patient monitoring devices has seen a significant surge recently. It is projected to increase from $8.39 billion in 2024 to $10.26 billion in 2025, yielding a compound annual growth rate (CAGR) of 22.2%. The historic upswing can be attributed to factors such as the growing incidence of chronic and cardiovascular diseases, enhanced demand for early detection and constant monitoring, an increase in the aging population needing sustained care, a gradual tilt towards home-based healthcare, and escalating healthcare expenses promoting preventive surveillance.
The market for implantable remote patient monitoring devices is set for substantial expansion in the upcoming years, with projections indicating that it could be valued at $22.59 billion in 2029, representing a compound annual growth rate (CAGR) of 21.8%. The anticipated surge in the market over the prediction period is largely owing to factors such as boosted governmental backing and reimbursement coverage, amplified awareness concerning precision medicine and personalized healthcare, expanded investment in MedTech startups and digital health, and an escalation in instances of post-operative complications and rehospitalization. Projected trends over the forecast period encompass progress in miniaturization and biocompatible materials, the incorporation of artificial intelligence (AI) and machine learning for anticipatory analytics, amalgamation with 5G and Internet of Things (IoT) networks, breakthroughs in battery-free implants and energy-harvesting, and advancements in cybersecurity protocols for medical implants.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27316&type=smp
What Elements Are Contributing To Growth In The Implantable Remote Patient Monitoring Devices Market?
The growth of the market for implantable remote patient monitoring devices is likely to be fuelled by the rising acceptance of telehealth services. These services, which involve the use of phones, video calls or apps for remote healthcare provision, let patients consult with physicians without needing to visit a clinic or hospital. The surge in the use of telehealth services can be attributed to the increasing need for consistent, real-time health tracking for those suffering from chronic diseases, as it promotes the appropriate timing of medical intervention without repeated hospital trips. Telehealth services enhance the functionality of implantable remote patient monitoring devices by facilitating immediate data exchange between patients and medical professionals, fostering timely medical decision-making and reducing the necessity for physical patient visits. Additionally, they optimize the management of chronic diseases through ongoing monitoring and early intervention, thereby maximizing healthcare efficacy and patient convenience. For example, the Australian Digital Health Agency revealed in May 2024 that between March 2020 and July 2022, telehealth services were used by over 95,000 practitioners and provided to 18 million patients, with a total of 118.2 million telehealth services delivered. As a result, the expanding adoption of telehealth services is stimulating the growth of the implantable remote patient monitoring devices market.
Which Segments Are Detailed In The Global Implantable Remote Patient Monitoring Devices Market Report?
The implantable remote patient monitoring devices market covered in this report is segmented
1) By Product: Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Weight Monitoring Devices, Other Products
2) By Application: Cardiovascular Diseases, Neurological Disorders, Diabetes, Other Applications
3) By End User: Hospital, Ambulatory Surgery Centers, Home Care Settings, Other End Users
Subsegments:
1) By Blood Glucose Monitoring Systems: Continuous Glucose Monitoring (CGM) Devices, Self-Monitoring Blood Glucose (SMBG) Devices, Lancets And Lancing Devices, Glucose Test Strips, Blood Glucose Meters,
2) By Cardiac Monitoring Devices: Electrocardiogram (ECG) Devices, Implantable Loop Recorders, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry Devices,
3) By Weight Monitoring Devices: Digital Weighing Scales, Smart Body Composition Monitors, Infant Scales, Chair Scales, Bed Scales,
4) By Other Products: Respiratory Monitoring Devices, Multiparameter Monitors, Fetal And Neonatal Monitoring Devices, Temperature Monitoring Devices, Neuromonitoring Devices
Which Emerging Trends And Strategic Shifts Are Shaping The Implantable Remote Patient Monitoring Devices Market?
Prominent firms in the implantable remote patient monitoring devices market are concentrating on the production of cutting-edge products like implantable cardiac monitors, enabling more precise observation of cardiac arrhythmias. An implantable cardiac monitor (ICM), also called an implantable loop recorder (ILR), is a compact device placed just under the skin, commonly on the chest’s left side, to incessantly track and document the heart’s electrical activity for a considerable duration. For example, Biotronik AG, a healthcare technology company based in Switzerland, in June 2023, launched the BIOMONITOR IV implantable cardiac monitor. This advanced ICM uses BIOTRONIK’s SmartECG technology and artificial intelligence, reducing false positive detections by 86%, while maintaining 98% of true episodes. This monitoring device can also differentiate premature atrial contractions (PACs) from premature ventricular contractions (PVCs), offering healthcare professionals superior tools for risk stratification and diagnosis.
Who Are The Key Contributors To Growth In The Implantable Remote Patient Monitoring Devices Market?
Major companies operating in the implantable remote patient monitoring devices market are Abbott Laboratories, Honeywell Life Sciences, Medtronic plc, Siemens Healthineers, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Dexcom Inc., Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova PLC, MicroPort Scientific Corporation, iRhythm Technologies Inc., NeuroPace Inc., Profusa Inc., Senseonics Holdings Inc., Xeltis AG, GlySens Inc., Kenzen Inc., Qura Inc.
Get The Full Report Here:
Which Region Is Projected To Lead The Implantable Remote Patient Monitoring Devices Market By 2025?
North America was the largest region in the implantable remote patient monitoring devices market in 2024. The regions covered in the implantable remote patient monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27316&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model